IO Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 05/12/2025 | 6.17 M | $6.73 M | 0.00% | 9.37% |
| NOVO HOLDINGS A/S | 05/15/2025 | 3.35 M | $3.66 M | 0.00% | 5.09% |
| PFM HEALTH SCIENCES, LP | 05/15/2025 | 2.34 M | $2.55 M | 0.00% | 3.55% |
| MARSHALL WACE, LLP | 05/15/2025 | 2.11 M | $2.29 M | 0.00% | 3.20% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.65 M | $1.80 M | 0.00% | 2.51% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2025 | 864.20 K | $941.98 K | 0.00% | 1.31% |
| MORGAN STANLEY | 05/15/2025 | 789.46 K | $860.51 K | -8.11% | 1.20% |
| 05/07/2025 | 681.45 K | $742.78 K | -8.85% | 1.03% | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 05/14/2025 | 400.23 K | $436.26 K | -9.49% | 0.61% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 192.67 K | $210.01 K | 0.00% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 126.40 K | $137.78 K | 6.40% | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 05/15/2025 | 95.00 K | $103.55 K | 26.67% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 75.00 K | $81.75 K | -56.90% | 0.11% |
| XTX TOPCO LTD | 05/08/2025 | 50.49 K | $55.03 K | 80.05% | 0.08% |
| CITADEL ADVISORS LLC | 05/15/2025 | 45.56 K | $49.66 K | -83.16% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 33.31 K | $36.30 K | 0.00% | 0.05% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 30.86 K | $33.00 K | -49.12% | 0.05% |
| VONTOBEL HOLDING LTD. | 04/28/2025 | 20.03 K | $21.83 K | -38.69% | 0.03% |
| 05/02/2025 | 130 | $142 | 0.00% | 0.00% | |
| CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/14/2025 | 0 | $0 | -100.00% | 0.00% | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 04/16/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IO Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of IO Biotech, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 6.17 M
Novo Holdings A/S: 3.35 M
PFM Health Sciences, LP: 2.34 M
MARSHALL WACE, LLP: 2.11 M
BANK OF AMERICA CORP /DE/: 1.65 M
Pivotal bioVenture Partners Investment Advisor LLC: 864,197
28.94% of IO Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.35 M shares in the last 24 months. This purchase volume represents approximately $22.20 M in transactions.